Afinion HbA1c Dx— 510(k) K180296

Substantially Equivalent

Alere Technologies AS

FDA 510(k) clearance K180296 for Afinion HbA1c Dx, Substantially Equivalent on 2018-05-07. Applicant: Alere Technologies AS. Device class: 2.

Clearance details

Applicant
Alere Technologies AS
Product code
Code PDJ
Device class
Class 2
Regulation
21 CFR 862.1373
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Oslo, NO
Download summary PDFView on FDA.gov ↗

Recent devices under product code PDJ

view all

More clearances from Alere Technologies AS

view all

Recalls naming K180296

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K180296.

Data sourced from openFDA. This site is unofficial and independent of the FDA.